Pharmaceuticals Portfolio
Name
As of 11/22/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
13.9%
1 yr return
22.3%
3 Yr Avg Return
10.0%
5 Yr Avg Return
11.9%
Net Assets
$1.67 B
Holdings in Top 10
73.3%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 0.70%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover 29.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$0
IRA
N/A
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 11/22/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
FPHAX - Profile
Distributions
- YTD Total Return 13.9%
- 3 Yr Annualized Total Return 10.0%
- 5 Yr Annualized Total Return 11.9%
- Capital Gain Distribution Frequency Semi-Annually
- Net Income Ratio 1.10%
- Dividend Yield 0.4%
- Dividend Distribution Frequency SemiAnnual
Fund Details
-
Legal NamePharmaceuticals Portfolio
-
Fund Family NameFidelity Investments
-
Inception DateJul 11, 2001
-
Shares OutstandingN/A
-
Share ClassOther
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerKarim Suwwan de Felipe
Fund Description
FPHAX - Performance
Return Ranking - Trailing
Period | FPHAX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 13.9% | -27.4% | 19.9% | 6.92% |
1 Yr | 22.3% | -13.7% | 48.1% | 24.53% |
3 Yr | 10.0%* | -28.0% | 9.5% | 0.66% |
5 Yr | 11.9%* | -7.8% | 12.2% | 2.74% |
10 Yr | 8.4%* | 0.2% | 13.1% | 27.93% |
* Annualized
Return Ranking - Calendar
Period | FPHAX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | 3.6% | -12.6% | 19.0% | 38.99% |
2022 | -4.0% | -53.9% | 3.2% | 9.87% |
2021 | 0.2% | -39.6% | 24.2% | 51.97% |
2020 | 1.6% | -13.6% | 178.2% | 91.28% |
2019 | 21.0% | 3.8% | 63.8% | 50.38% |
Total Return Ranking - Trailing
Period | FPHAX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 13.9% | -27.4% | 19.9% | 6.92% |
1 Yr | 22.3% | -13.7% | 48.1% | 24.53% |
3 Yr | 10.0%* | -28.0% | 9.5% | 0.66% |
5 Yr | 11.9%* | -7.8% | 12.2% | 2.74% |
10 Yr | 8.4%* | 0.2% | 13.1% | 27.93% |
* Annualized
Total Return Ranking - Calendar
Period | FPHAX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | 12.5% | -12.6% | 19.0% | 9.43% |
2022 | 1.0% | -53.9% | 3.7% | 4.61% |
2021 | 11.8% | -33.9% | 26.0% | 33.55% |
2020 | 11.1% | -0.7% | 180.6% | 91.28% |
2019 | 31.6% | 4.6% | 63.8% | 25.56% |
NAV & Total Return History
FPHAX - Holdings
Concentration Analysis
FPHAX | Category Low | Category High | FPHAX % Rank | |
---|---|---|---|---|
Net Assets | 1.67 B | 6.66 M | 45.7 B | 34.59% |
Number of Holdings | 73 | 25 | 430 | 56.60% |
Net Assets in Top 10 | 1.4 B | 2.12 M | 22.1 B | 22.01% |
Weighting of Top 10 | 73.26% | 18.4% | 79.7% | 1.89% |
Top 10 Holdings
- ELI LILLY and CO 23.96%
- NOVO-NORDISK AS CL B ADR 13.34%
- ASTRAZENECA PLC SPONS ADR 8.80%
- BRISTOL-MYERS SQUIBB CO 4.96%
- UCB SA 4.75%
- GSK PLC SPONS ADR 4.49%
- MERCK and CO INC NEW 4.22%
- GILEAD SCIENCES INC 3.21%
- Fidelity Cash Central Fund 3.02%
- LEGEND BIOTECH CORP SPON ADR 2.51%
Asset Allocation
Weighting | Return Low | Return High | FPHAX % Rank | |
---|---|---|---|---|
Stocks | 96.34% | 87.34% | 106.13% | 81.76% |
Cash | 3.91% | 0.00% | 33.01% | 30.19% |
Preferred Stocks | 0.37% | 0.00% | 7.86% | 24.53% |
Bonds | 0.05% | 0.00% | 12.39% | 18.87% |
Other | 0.00% | -22.99% | 23.24% | 38.36% |
Convertible Bonds | 0.00% | 0.00% | 0.37% | 8.44% |
Stock Sector Breakdown
Weighting | Return Low | Return High | FPHAX % Rank | |
---|---|---|---|---|
Healthcare | 100.00% | 59.26% | 100.00% | 0.65% |
Utilities | 0.00% | 0.00% | 0.00% | 1.30% |
Technology | 0.00% | 0.00% | 22.69% | 8.44% |
Real Estate | 0.00% | 0.00% | 5.89% | 5.19% |
Industrials | 0.00% | 0.00% | 7.02% | 7.14% |
Financial Services | 0.00% | 0.00% | 1.60% | 27.92% |
Energy | 0.00% | 0.00% | 0.00% | 1.30% |
Communication Services | 0.00% | 0.00% | 9.11% | 4.55% |
Consumer Defense | 0.00% | 0.00% | 25.73% | 11.69% |
Consumer Cyclical | 0.00% | 0.00% | 1.92% | 7.14% |
Basic Materials | 0.00% | 0.00% | 7.16% | 33.12% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | FPHAX % Rank | |
---|---|---|---|---|
US | 87.67% | 66.06% | 104.41% | 68.55% |
Non US | 8.67% | 0.00% | 28.87% | 34.59% |
Bond Sector Breakdown
Weighting | Return Low | Return High | FPHAX % Rank | |
---|---|---|---|---|
Cash & Equivalents | 3.91% | 0.00% | 100.00% | 29.56% |
Derivative | 0.00% | 0.00% | 23.24% | 22.01% |
Securitized | 0.00% | 0.00% | 0.00% | 1.45% |
Corporate | 0.00% | 0.00% | 81.57% | 19.57% |
Municipal | 0.00% | 0.00% | 0.00% | 1.45% |
Government | 0.00% | 0.00% | 29.44% | 2.17% |
Bond Geographic Breakdown
Weighting | Return Low | Return High | FPHAX % Rank | |
---|---|---|---|---|
US | 0.05% | 0.00% | 11.75% | 18.87% |
Non US | 0.00% | 0.00% | 3.33% | 2.52% |
FPHAX - Expenses
Operational Fees
FPHAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 0.70% | 0.08% | 4.48% | 76.73% |
Management Fee | 0.69% | 0.03% | 1.25% | 52.83% |
12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
FPHAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | N/A | 3.50% | 5.75% | N/A |
Deferred Load | N/A | 1.00% | 1.00% | N/A |
Trading Fees
FPHAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 1.00% | 70.73% |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
FPHAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 29.00% | 0.00% | 238.00% | 21.48% |
FPHAX - Distributions
Dividend Yield Analysis
FPHAX | Category Low | Category High | FPHAX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.40% | 0.00% | 6.24% | 10.69% |
Dividend Distribution Analysis
FPHAX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | SemiAnnual | Annual | Monthly | Annual |
Net Income Ratio Analysis
FPHAX | Category Low | Category High | FPHAX % Rank | |
---|---|---|---|---|
Net Income Ratio | 1.10% | -2.54% | 1.85% | 5.92% |
Capital Gain Distribution Analysis
FPHAX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Semi-Annually | Annually | Annually | Annually |
Distributions History
Date | Amount | Type |
---|---|---|
Apr 12, 2024 | $0.053 | OrdinaryDividend |
Apr 12, 2024 | $0.174 | CapitalGainLongTerm |
Dec 21, 2023 | $0.148 | OrdinaryDividend |
Dec 21, 2023 | $0.268 | CapitalGainShortTerm |
Dec 21, 2023 | $0.456 | CapitalGainLongTerm |
Apr 14, 2023 | $1.035 | CapitalGainLongTerm |
Dec 16, 2022 | $0.925 | OrdinaryDividend |
Apr 08, 2022 | $0.256 | OrdinaryDividend |
Dec 17, 2021 | $1.856 | OrdinaryDividend |
Apr 09, 2021 | $0.775 | OrdinaryDividend |
Dec 18, 2020 | $1.459 | OrdinaryDividend |
Apr 08, 2020 | $0.637 | OrdinaryDividend |
Dec 20, 2019 | $0.224 | OrdinaryDividend |
Dec 20, 2019 | $0.223 | CapitalGainShortTerm |
Dec 20, 2019 | $0.942 | CapitalGainLongTerm |
Apr 05, 2019 | $0.081 | OrdinaryDividend |
Apr 05, 2019 | $0.471 | CapitalGainLongTerm |
Dec 14, 2018 | $0.216 | OrdinaryDividend |
Dec 14, 2018 | $0.048 | CapitalGainLongTerm |
Apr 06, 2018 | $0.062 | OrdinaryDividend |
Apr 06, 2018 | $0.054 | CapitalGainShortTerm |
Dec 15, 2017 | $0.224 | OrdinaryDividend |
Dec 15, 2017 | $0.053 | CapitalGainShortTerm |
Apr 07, 2017 | $0.023 | OrdinaryDividend |
Dec 16, 2016 | $0.183 | OrdinaryDividend |
Dec 18, 2015 | $0.136 | OrdinaryDividend |
Dec 18, 2015 | $0.243 | CapitalGainShortTerm |
Dec 18, 2015 | $1.240 | CapitalGainLongTerm |
Apr 13, 2015 | $0.035 | OrdinaryDividend |
Apr 13, 2015 | $0.180 | CapitalGainShortTerm |
Apr 13, 2015 | $0.763 | CapitalGainLongTerm |
Dec 22, 2014 | $0.089 | OrdinaryDividend |
Dec 22, 2014 | $0.159 | CapitalGainShortTerm |
Dec 22, 2014 | $0.889 | CapitalGainLongTerm |
Apr 14, 2014 | $0.086 | OrdinaryDividend |
Apr 14, 2014 | $0.351 | CapitalGainShortTerm |
Apr 14, 2014 | $0.631 | CapitalGainLongTerm |
Dec 23, 2013 | $0.122 | OrdinaryDividend |
Dec 23, 2013 | $1.547 | CapitalGainLongTerm |
Apr 15, 2013 | $0.060 | OrdinaryDividend |
Apr 15, 2013 | $0.036 | CapitalGainShortTerm |
Apr 15, 2013 | $0.190 | CapitalGainLongTerm |
Dec 26, 2012 | $0.151 | OrdinaryDividend |
Dec 26, 2012 | $0.024 | CapitalGainShortTerm |
Dec 26, 2012 | $0.215 | CapitalGainLongTerm |
Apr 16, 2012 | $0.045 | OrdinaryDividend |
Apr 16, 2012 | $0.035 | CapitalGainLongTerm |
Dec 12, 2011 | $0.077 | OrdinaryDividend |
Dec 12, 2011 | $0.087 | CapitalGainLongTerm |
Apr 07, 2011 | $0.035 | OrdinaryDividend |
Apr 07, 2011 | $0.110 | CapitalGainShortTerm |
Apr 07, 2011 | $0.115 | CapitalGainLongTerm |
Dec 13, 2010 | $0.110 | OrdinaryDividend |
Dec 13, 2010 | $0.050 | CapitalGainShortTerm |
Dec 13, 2010 | $0.090 | CapitalGainLongTerm |
Apr 12, 2010 | $0.020 | OrdinaryDividend |
Apr 12, 2010 | $0.050 | CapitalGainLongTerm |
Dec 14, 2009 | $0.115 | OrdinaryDividend |
Apr 20, 2009 | $0.040 | OrdinaryDividend |
Dec 15, 2008 | $0.110 | OrdinaryDividend |
Apr 14, 2008 | $0.020 | OrdinaryDividend |
Apr 14, 2008 | $0.060 | CapitalGainLongTerm |
Dec 17, 2007 | $0.070 | OrdinaryDividend |
Dec 17, 2007 | $0.010 | CapitalGainShortTerm |
Dec 17, 2007 | $0.280 | CapitalGainLongTerm |
Apr 16, 2007 | $0.040 | OrdinaryDividend |
Apr 16, 2007 | $0.190 | CapitalGainLongTerm |
Dec 18, 2006 | $0.030 | OrdinaryDividend |
Apr 10, 2006 | $0.010 | OrdinaryDividend |
Apr 10, 2006 | $0.120 | CapitalGainShortTerm |
Apr 10, 2006 | $0.190 | CapitalGainLongTerm |
Dec 19, 2005 | $0.010 | OrdinaryDividend |
Apr 11, 2005 | $0.005 | OrdinaryDividend |
FPHAX - Fund Manager Analysis
Managers
Karim Suwwan de Felipe
Start Date
Tenure
Tenure Rank
Jul 01, 2017
4.92
4.9%
Karim Suwwan de Felipe is portfolio manager of Pharmaceuticals Portfolio, which he has managed since July 2017. Since joining Fidelity Investments in 2010, Mr. Suwwan de Felipe has worked as a research analyst and portfolio manager
Tenure Analysis
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.02 | 24.72 | 7.88 | 0.25 |